United States (USA) Hip Reconstruction Market Size (Value, Volume, ASP) by Segments (Hip Resurfacing, Partial Hip Replacement and Others), Share and Forecast, 2015-2025

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4995
Buy Report

Published: January 29, 2021 Report Code: GDMECC5947DB-ST

Select Item

GlobalData’s “United States Hip Reconstruction Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States Hip Reconstruction market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Hip Resurfacing, Partial Hip Replacement, Primary Hip Replacement and Revision Hip Replacement.

The United States Hip Reconstruction Market report provides key information and data on:
• Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2015 to 2025.
• 2019 company share and distribution share data for Hip Reconstruction Market.
• Global corporate-level profiles of key companies operating within the United States Hip Reconstruction Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United States Hip Reconstruction is segmented as follows:

• Hip Resurfacing

• Partial Hip Replacement

• Primary Hip Replacement

• Revision Hip Replacement

Reasons to Buy

Key Reasons to Purchase – The United States Hip Reconstruction Market report helps you to develop:

• Business strategies by identifying the key market segments poised for strong growth in the future.

• Market-entry and market expansion strategies.

• Design competition strategies by identifying who-stands-where in the market.

• Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

• Understand the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Key companies covered in the “United States Hip Reconstruction Market Outlook to 2025” report:
• Zimmer Biomet Holdings Inc
• Stryker Corp
• DePuy Synthes Inc

Table of Contents

1 Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 5

2 Introduction 6

2.1 What Is This Report About? 6

2.2 Hip Reconstruction Segmentation 6

2.3 Definitions of Markets Covered in the Report 7

3 Hip Reconstruction Market, United States 9

3.1 Hip Reconstruction Market, United States, Revenue ($m), 2015-2025 9

3.1.1 Partial Hip Replacement Market, United States, Revenue ($m), by Segment, 2015-2025 11

3.1.2 Primary Hip Replacement Market, United States, Revenue ($m), by Segment, 2015-2025 13

3.2 Hip Reconstruction Market, United States, Volume (Units), 2015-2025 15

3.2.1 Partial Hip Replacement Market, United States, Volume (Units), by Segment, 2015-2025 17

3.2.2 Primary Hip Replacement Market, United States, Volume (Units), by Segment, 2015-2025 19

3.3 Hip Reconstruction Market, United States, Average Price ($) , 2015-2025 21

3.4 Hip Reconstruction Market, United States, Distribution Share by Revenue ($m), 2019 23

3.5 Hip Reconstruction Market, United States, Company Share by Revenue ($m), 2019 24

4 Overview of Key Companies in United States, Hip Reconstruction Market 26

4.1 Zimmer Biomet Holdings Inc 26

4.1.1 Company Overview 26

4.2 Stryker Corp 26

4.2.1 Company Overview 26

4.3 DePuy Synthes Inc 26

4.3.1 Company Overview 26

4.4 Smith & Nephew Plc 27

4.4.1 Company Overview 27

4.5 MicroPort Scientific Corp 27

4.5.1 Company Overview 27

4.6 Exactech Inc 27

4.6.1 Company Overview 27

4.7 Medacta Group SA 27

4.7.1 Company Overview 27

5 Hip Reconstruction Market Pipeline Products 28

6 Financial Deals Landscape 29

6.1 Debt Offerings 29

6.1.1 Stryker Prices USD600 Million in Public Offering of

0.600% Senior Notes Due 2023 29

6.1.2 Stryker Raises USD650 Million in Public Offering of

1.15% Notes Due 2025 30

6.1.3 Stryker Raises USD1 Billion in Public Offering of

1.95% Notes Due 2030 32

6.1.4 Stryker Raises USD650 Million in Public Offering of

2.9% Notes Due 2050 34

6.1.5 Zimmer Biomet Prices Public Offering of

3.55% Notes Due 2030 for USD900 Million 36

6.1.6 Zimmer Biomet Prices Public Offering of

3.05% Notes Due 2026 for USD600 Million 38

6.2 Equity Offerings 40

6.2.1 SINTX Technologies Plans to Raise up to USD75 Million in Public Offering of Securities 40

6.2.2 SINTX Technologies to Raise USD8.19 Million in Public Offering of Shares 41

6.2.3 SINTX Technologies Prices Private Placement of Shares for USD3 Million 43

6.2.4 SINTX Technologies to Raise USD41.3 Million in Public offering of Shares 44

6.2.5 SINTX Technologies Prices Private Placement of Shares for USD5.6 Million 46

6.2.6 Sintx Technologies to Raise USD8.8 million in Rights Offering 47

7 Recent Developments 49

7.1 Corporate Communications 49

7.1.1 Mar 05, 2020: Ovid Therapeutics announces presentations on OV935/TAK935 (soticlestat) at the American Academy of Neurology 2020 Annual Meeting 49

7.1.2 Mar 02, 2020: Stryker announces new Investor Relations leader 49

7.1.3 Feb 25, 2020: Stryker announces nomination of new Director, Lisa Skeete Tatum 50

7.1.4 Feb 06, 2020: Henry Ford Health System announces new president and CEO Of Health Alliance Plan 50

7.1.5 Feb 04, 2020: Henry Ford Medical Group names new Chair of Board of Governors 51

7.1.6 Jan 25, 2020: Siemens Healthineers India launches ACUSON Redwood Ultrasound System at IRIA 2020 51

7.1.7 Jan 22, 2020: Amiri Hospital in Kuwait goes lives with Agfa HealthCare’s Enterprise Imaging for Radiology 52

7.1.8 Jan 08, 2020: Zimmer Biomet appoints Keri P. Mattox as Senior Vice President of Investor Relations and Chief Communications Officer 54

7.1.9 Jan 06, 2020: Exactech announces leadership transition 54

7.2 Financial Announcements 55

7.2.1 Feb 04, 2020: Zimmer Biomet announces fourth quarter and full-year 2019 financial results 55

7.2.2 Jan 28, 2020: Stryker reports 2019 results and 2020 outlook 55

7.3 Government and Public Interest 56

7.3.1 Jun 30, 2020: HSS study identifies RA patients with worse outcomes after hip or knee replacement 56

7.4 Other Significant Developments 57

7.4.1 Sep 16, 2020: Willamette Surgery Center now offering highly advanced robotic-arm assisted joint replacement procedures with Stryker's mako system 57

7.4.2 Jun 29, 2020: DePuy Synthes renews cooperation agreement with AO Foundation to continue advancement of surgical education 58

7.4.3 May 28, 2020: Conformis announces settlement of patent dispute 58

7.5 Product News 58

7.5.1 Jun 08, 2020: No difference in outcomes between anterior and posterior surgical approaches for outpatient total hip replacement 58

7.6 Strategy And Business Planning 59

7.6.1 Feb 20, 2020: Galderma announces New England Journal of Medicine publication from phase 2 study of investigational therapy Nemolizumab in patients with moderate to severe Prurigo Nodularis 59

7.6.2 Jan 23, 2020: Brainlab acquires San Diego-based VisionTree Software 60

7.6.3 Jan 16, 2020: New Bloomfield Township Medical Center: Enhancing the care experience 60

8 Appendix 62

8.1 Research Methodology 63

8.1.1 Coverage 63

8.1.2 Secondary Research 63

8.1.3 Primary Research 64

8.1.4 Market Modeling and Forecasting 65

8.1.5 Company Share Analysis 66

8.1.6 Distribution Share Analysis 66

8.1.7 Benchmarking 67

8.2 GlobalData Consulting 67

8.3 Contact Us 68

8.4 Disclaimer 68

Table

1.1 List of Tables

Table 1: Hip Reconstruction Market, United States, Revenue ($m), USD Constant, 2015-2020 10

Table 2: Hip Reconstruction Market, United States, Revenue ($m), USD Constant, 2021-2025 10

Table 3: Partial Hip Replacement Market, United States, Revenue ($m), USD Constant, 2015-2020 12

Table 4: Partial Hip Replacement Market, United States, Revenue ($m), USD Constant, 2021-2025 12

Table 5: Primary Hip Replacement Market, United States, Revenue ($m), USD Constant, 2015-2020 14

Table 6: Primary Hip Replacement Market, United States, Revenue ($m), USD Constant, 2021-2025 14

Table 7: Hip Reconstruction Market, United States, Volume (Units), 2015-2020 16

Table 8: Hip Reconstruction Market, United States, Volume (Units), 2021-2025 16

Table 9: Partial Hip Replacement Market, United States, Volume (Units), 2015-2020 18

Table 10: Partial Hip Replacement Market, United States, Volume (Units), 2021-2025 18

Table 11: Primary Hip Replacement Market, United States, Volume (Units), 2015-2020 20

Table 12: Primary Hip Replacement Market, United States, Volume (Units), 2021-2025 20

Table 13: Hip Reconstruction Market, United States, Average Price ($), 2015-2020 21

Table 14: Hip Reconstruction Market, United States, Average Price ($), 2021-2025 22

Table 15: Hip Reconstruction Market, United States, Distribution Share by Revenue ($m), USD Constant, 2019 23

Table 16: Hip Reconstruction Market, United States, Company Share by Revenue ($m), USD Constant, 2019 25

Table 17: Hip Reconstruction Market Pipeline Products 28

Table 18: Stryker Prices USD600 Million in Public Offering of 0.600% Senior Notes Due 2023 29

Table 19: Stryker Raises USD650 Million in Public Offering of 1.15% Notes Due 2025 30

Table 20: Stryker Raises USD1 Billion in Public Offering of 1.95% Notes Due 2030 32

Table 21: Stryker Raises USD650 Million in Public Offering of 2.9% Notes Due 2050 34

Table 22: Zimmer Biomet Prices Public Offering of 3.55% Notes Due 2030 for USD900 Million 36

Table 23: Zimmer Biomet Prices Public Offering of 3.05% Notes Due 2026 for USD600 Million 38

Table 24: SINTX Technologies Plans to Raise up to USD75 Million in Public Offering of Securities 40

Table 25: SINTX Technologies to Raise USD8.19 Million in Public Offering of Shares 41

Table 26: SINTX Technologies Prices Private Placement of Shares for USD3 Million 43

Table 27: SINTX Technologies to Raise USD41.3 Million in Public offering of Shares 44

Table 28: SINTX Technologies Prices Private Placement of Shares for USD5.6 Million 46

Table 29: Sintx Technologies to Raise USD8.8 million in Rights Offering 47

Table 30: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country 65

Figures

1.2 List of Figures

Figure 1: Hip Reconstruction Market, United States, Revenue ($m), USD Constant, 2015-2025 9

Figure 2: Partial Hip Replacement Market, United States, Revenue ($m), USD Constant, 2015-2025 11

Figure 3: Primary Hip Replacement Market, United States, Revenue ($m), USD Constant, 2015-2025 13

Figure 4: Hip Reconstruction Market, United States, Volume (Units), 2015-2025 15

Figure 5: Partial Hip Replacement Market, United States, Volume (Units), 2015-2025 17

Figure 6: Primary Hip Replacement Market, United States, Volume (Units), 2015-2025 19

Figure 7: Hip Reconstruction Market, United States, Company Share (%) 2019 24

Frequently asked questions

United States (USA) Hip Reconstruction Market Size (Value, Volume, ASP) by Segments (Hip Resurfacing, Partial Hip Replacement and Others), Share and Forecast, 2015-2025 standard reports
Currency USD
$4,995

Can be used by individual purchaser only

Most Popular
$9,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$14,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Orthopedic Devices reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at United States (USA) Hip Reconstruction Market Size (Value, Volume, ASP) by Segments (Hip Resurfacing, Partial Hip Replacement and Others), Share and Forecast, 2015-2025 in real time.

  • Access a live United States (USA) Hip Reconstruction Market Size (Value, Volume, ASP) by Segments (Hip Resurfacing, Partial Hip Replacement and Others), Share and Forecast, 2015-2025 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more